CHASE is a major community systems change initiative in 16 New York State (NYS) counties (8 intervention, 8 control) to reduce opioid overdose mortality by 40%. CHASE is a coordinated […]
Innovative models for delivering HIV and HCV care, HIV prevention (PrEP), and OUD medication at SSPs can expand PWID treatment access, uptake and engagement, but they are not well described […]
This project investigates the role of the human microbiome in cancer by applying novel and state-of-the-art methods to published metagenomic data, and provides enhanced, expanded, and more efficiently usable microbiome […]
This project extends on Prof. Waldron’s interests on the role of the human microbiome as an ongoing link between host and environment, and its role in human health and disease. As […]
This study assesses the effectiveness of the Staying Safe (Ssafe) intervention in reducing both injection-related Hepatitis C (HCV) and HIV risk behavior, and HCV incidence among young adults (ages 18-29) […]
The New York Delivery System Reform Incentive Payment Program (DSRIP) provides a unique opportunity for collaboration to address HIV at the population level in New York City. To best address […]
This study examines the feasibility, acceptability, safety, effectiveness, and cost of an Accessible Care intervention for engaging people who inject illicit drugs in hepatitis C care. Four times as prevalent […]
This project aims to resolve controversy around the clinical relevance of ovarian cancer subtypes by two main approaches. First, subtype robustness and association to patient outcome are assessed by comparative […]
This study is designed to adapt and evaluate an innovative, engaging mHealth intervention to prevent young opioid users (18-29) from transitioning to injection drug users (IDU). This intervention has the […]
This project is a supplement with the DOHMH to design, develop, implement and conduct a usability evaluation of an interactive, internet enabled human centered SMAART dashboard. The dashboard will facilitate […]